Multiple Testing Procedures in Two Pivotal Clinical Trials for Approval of a New Pharmaceutical Product

ISSN： 1054-3406

Source： Journal of Biopharmaceutical Statistics, Vol.21, Iss.4, 2011-07, pp. : 669-681

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Statistical Considerations for Testing Multiple Endpoints in Group Sequential or Adaptive Clinical Trials

By Hung H. M. James

Journal of Biopharmaceutical Statistics, Vol. 17, Iss. 6, 2007-11 ,pp. : 1201-1210

Taylor & Francis Ltd

Access to resources Recommend Favorite

The new pharmaceutical regulatory procedures for Europe

By Jefferys D.B.

Trends in Pharmacological Sciences, Vol. 16, Iss. 7, 1995-07 ,pp. : 226-231

Elsevier

Access to resources Recommend Favorite

Selenium and Clinical Trials: New Therapeutic Evidence for Multiple Diseases

Current Medicinal Chemistry, Vol. 18, Iss. 30, 2011-10 ,pp. : 4635-4650

Bentham Science Publishers

Access to resources Recommend Favorite

Multiple Comparisons of Repeatedly Measured Response: Issues of Validation Testing in Thorough QT/QTc Clinical Trials

By Tsong Yi Yan Lihan Zhong Jinglin Nie Lei Zhang Joanne

Journal of Biopharmaceutical Statistics, Vol. 20, Iss. 3, 2010-05 ,pp. : 654-664

Taylor & Francis Ltd

Access to resources Recommend Favorite

Multistage and Mixture Parallel Gatekeeping Procedures in Clinical Trials

By Dmitrienko Alex

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 4, 2011-07 ,pp. : 726-747

Taylor & Francis Ltd

Access to resources Recommend Favorite